Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

33.19
BATS BZX Real-Time Price
As of 10:46am ET
 +0.75 / +2.31%
Today’s Change
31.83
Today|||52-Week Range
52.10
-22.38%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close32.44
Today’s open32.63
Day’s range32.13 - 33.81
Volume47,847
Average volume (3 months)754,440
Market cap$2.3B
Dividend yield--
Data as of 10:46am ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)-3.94%
Earnings growth (next 5 years)+24.96%
Revenue growth (last year)+16.53%
P/E ratio87.8
Price/Sales3.75
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+6.11+6.51%
MYGNMyriad Genetics Inc+0.38+1.10%
ACADACADIA Pharmaceutica...+0.65+3.52%
MDCOMedicines Co-0.28-0.95%
Data as of 10:49am ET, 02/10/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

Partner Offers